Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 338 followers
Latest posts
Last updated about 3 hours ago
Fecal transplant increases tolerance to peanuts sixfold in small food allergy trial
about 3 hours ago
Fecal transplants can increase tolerance to peanuts sixfold in people with food...
Sanofi suspends chronic lung disease phase 2 study, tied to ‘strategic business reasons’
about 3 hours ago
Sanofi halted a phase 2 trial testing a monoclonal antibody, SAR445399, in...
Lilly drops another gene therapy trial from $1B Prevail buyout
about 8 hours ago
Eli Lilly has axed another trial of a gene therapy acquired in...
Novo CEO accepts ‘couple of setbacks’ in R&D as CagriSema posts more mixed data
about 9 hours ago
Novo Nordisk’s CEO admitted the Danish pharma has had “a couple of...
Attovia's CEO aims to scratch itch opportunity and challenge Dupixent with $289M IPO
about 10 hours ago
Attovia Therapeutics has accreted a hefty $289 million from its IPO to...
Sanofi-backed Expedition uses $115M series B to advance COPD drug on phase 2 journey
about 10 hours ago
Expedition Therapeutics has secured an oversubscribed $115 million series B financing from...
Icon inks Anthropic partnership to deploy Claude into clinical trials
1 day ago
Contract research organization Icon announced a multi-year collaboration with Anthropic this week...
Smith & Nephew cuts 2026 outlook as US knee implant sales slide
1 day ago
Smith & Nephew has lowered its 2026 sales outlook after weakness in...
Amgen drops early-stage obesity drug, upping pressure on MariTide
1 day ago
Amgen has ended development of its early-stage obesity drug AMG 513, foisting...
Lisata lays off 72% of staffers, sues Kuva after planned merger falls apart
1 day ago
Lisata is laying off 72% of its workforce, including its chief medical...
Fiercest Women in Life Sciences 2026: Nominations open now
1 day ago
Who should be a 2026 Fiercest Woman in Life Sciences? Nominations are...
Pfizer axes ex-Metsera obesity asset and GIPR prospect in quarterly clearout
1 day ago
Pfizer has axed two clinical-stage obesity programs, dropping a GLP-1 receptor agonist...